peter attia on semaglutide 320 – AMA 64: New insights GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape Ozempic for Weight Loss: Is

Compounded medications may not be suitable if you have difficulty with manual dexterity or vision problems that make measuring precise doses challenging

However, the introduction of semaglutide tablets and the development of higher-dose oral Read More GLP1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C Jan 26, 2026 Articles, Diabetes, Featured, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 2,583 views Nonalcoholic steatohepatitis (NASH) and metabolic dysfunctionassociated steatotic liver disease (MASLD) are rapidly becoming leading causes of chronic liver disease worldwide

A study from the New England Journal of Medicine found new evidence that GLP-1 drugs, like Ozempic and Wegovy, used for diabetes and obesity could also help people with a type of liver disease

I am optimistic about the progress toward my weight loss goals

It is not indicated for type 1 diabetes or for the treatment of diabetic ketoacidosis

Like, where would you start from that point to break down to the microhabits